Peptide Profile
DSIP (Delta Sleep-Inducing Peptide)
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide that was first discovered in 1974. Isolated from the venous blood of rabbits induced into a state of deep sleep.
1. Chemical Structure and Biochemistry
DSIP is a very short, simple chain of amino acids capable of crossing the blood-brain barrier.
- Peptide Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
- Unlike many synthetic peptides, DSIP is an amphiphilic naturally occurring molecule found in the brain, peripheral organs, and plasma of humans and other mammals.
2. Mechanism of Action
The precise neuronal receptor for DSIP remains somewhat elusive; however, its pharmacological profile indicates broad systemic regulatory roles.
- Sleep Architecture: It modulates EEG activity in the brain, explicitly increasing the prevalence of slow-wave sleep (Delta rhythm) and sleep spindles without functioning as a traditional sedative-hypnotic.
- Hormonal Modulation: Interacts with the hypothalamus-pituitary-adrenal (HPA) axis, modulating the release of corticotropin, suppressing cortisol, and promoting luteinizing hormone release.
3. Research and Applications
DSIP has an exceptionally broad range of theoretical and experimental applications beyond sleep.
- Sleep Disorders: Studied as a treatment for insomnia and narcolepsy to normalize sleep architecture.
- Stress and Addiction: Investigated for its ability to blunt the physiological response to acute stress and reduce withdrawal symptoms in models of alcohol and opiate addiction.
- Analgesia: Explored as an adjunct for chronic pain management due to its interaction with endogenous opioid pathways.
Tags:
DSIP
Delta-Sleep-Inducing-Peptide
nonapeptide
slow-wave-sleep
circadian-rhythm
insomnia
cortisol-suppression
HPA-axis
stress-reduction